Novel Combination Therapy Offers Hope for Immunotherapy-Resistant Aggressive Lymphoma
In a groundbreaking advancement for the treatment of relapsed or refractory natural killer/T-cell lymphoma (R/R NKTL), researchers have unveiled a ...
In a groundbreaking advancement for the treatment of relapsed or refractory natural killer/T-cell lymphoma (R/R NKTL), researchers have unveiled a ...
Cancer immunotherapy has revolutionized the treatment landscape for several malignancies by mobilizing the adaptive immune system, particularly T cells, to ...
In the relentless battle against breast cancer, researchers have long sought to understand the elusive mechanisms that fuel tumor resilience ...
Nearly Four Decades After Its Discovery, a Well-Known Protein Emerges as a Key Player in Cancer Immune Evasion For nearly ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine